http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
CFD analysis of the effect of different PAR locations against hydrogen recombination rate
Lee, Khor Chong,Ryu, Myungrok,Park, Kweonha The Korean Society of Marine Engineering 2016 한국마린엔지니어링학회지 Vol.40 No.2
Many studies have been conducted on the performance of a passive autocatalytic recombiner (PAR), but not many have focused on the locations where the PAR is installed. During a severe accident in a nuclear reactor containment, a large amount of hydrogen gas can be produced and released into the containment, leading to hydrogen deflagration or a detonation. A PAR is a hydrogen mitigation method that is widely implemented in current and advanced light water reactors. Therefore, for this study, a PAR was installed at different locations in order to investigate the difference in hydrogen reduction rate. The results indicate that the hydrogen reduction rate of a PAR is proportional to the distance between the hydrogen induction location and the bottom wall.
Proposal and Analysis of Hydrogen Mitigation System Guiding Hydrogen in Containment Building
Park, Kweonha,Lee, Khor Chong The Korean Society of Marine Engineering 2015 한국마린엔지니어링학회지 Vol.39 No.5
This study is about a hydrogen mitigation system in a containment building like an offshore or a nuclear plant. A hydrogen explosion is possibly happened after condensation of steam if hydrogen releases with steam in a containment buildings. Passive autocatalytic recombiner is the one of the measures, but the performance of this equipment is not sure because the distribution of hydrogen is very irregular and is not predicted correctly. This study proposes a new approach for improving the hydrogen removing performance with hydrogen-guiding property. The steam is simulated and analysed. The results show that the shallow air containment reduced over 55% of the released hydrogen and the deep air containment type reduces over 80% of released hydrogen.
Terence Ing Wei Ong,Lee Ling Lim,Siew Pheng Chan,Winnie Siew Swee Chee,Alan Swee Hock Ch’ng,Elizabeth Gar Mit Chong,Premitha Damodaran,Fen Lee Hew,Luqman bin Ibrahim,Hui Min Khor,Pauline Siew Mei Lai 대한골다공증학회 2023 Osteoporosis and Sarcopenia Vol.9 No.2
Objectives: The aim of these Clinical Practice Guidelines is to provide evidence-based recommendations to assist healthcare providers in the screening, diagnosis and management of patients with postmenopausal osteoporosis (OP). Methods: A list of key clinical questions on the assessment, diagnosis and treatment of OP was formulated. A literature search using the PubMed, Medline, Cochrane Databases of Systematic Reviews, and OVID electronic databases identified all relevant articles on OP based on the key clinical questions, from 2014 onwards, to update from the 2015 edition. The articles were graded using the SIGN50 format. For each statement, studies with the highest level of evidence were used to frame the recommendation. Results: This article summarizes the diagnostic and treatment pathways for postmenopausal OP. Risk stratification of patients with OP encompasses clinical risk factors, bone mineral density measurements and FRAX risk estimates. Non-pharmacological measures including adequate calcium and vitamin D, regular exercise and falls prevention are recommended. Pharmacological measures depend on patients’ fracture risk status. Very high-risk individuals are recommended for treatment with an anabolic agent, if available, followed by an anti-resorptive agent. Alternatively, parenteral anti-resorptive agents can be used. High-risk individuals should be treated with anti-resorptive agents. In low-risk individuals, menopausal hormone replacement or selective estrogen receptor modulators can be used, if indicated. Patients should be assessed regularly to monitor treatment response and treatment adjusted, as appropriate.